EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Durability of Respiratory Syncytial Virus Antibodies After Vaccination in Immunosuppressed Persons

Zeba Nauroz, Prasanthy Balasubramanian iD, Moreno Rodrigues, Shreya Arondekar iD, Isabella Sengsouk, Camille Hage iD, Maggie Chahoud iD, Xori Green, Woudase Gallo, Yolanda Eby, Aaron A R Tobian, William A Werbel iD und 1 weitere

Open Forum Infectious Diseases · 01.08.2026 · 13 (8)

DOI: 10.1093/ofid/ofag453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 23.07.2026. Verfasst von Zeba Nauroz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Willowcroft Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory syncytial virus (RSV) antibody durability in immunosuppressed persons following RSV vaccination is unknown. In this observational cohort of immunosuppressed persons, peak responses occurred 1 month after vaccination, without significant waning by 6 months; adjuvanted vaccine recipients had higher responses. This suggests RSV antibody durability of at least 6 months and potential augmentation by adjuvanted vaccine.

Schlagwörter

Stichwörter der Autor:innen

RSVimmunocompromisedvaccine

Autor:innen und Institutionen

  • Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Prasanthy Balasubramanian, Shreya Arondekar, Camille Hage, Maggie Chahoud, William A Werbel, Andrew H Karaba

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Willowcroft Foundation

Zitieren

APA

Nauroz, Z., Balasubramanian, P., Rodrigues, M., Arondekar, S., Sengsouk, I., Hage, C., Chahoud, M., Green, X., Gallo, W., Eby, Y., Tobian, A. A. R., Werbel, W. A., & Karaba, A. H. (2026). Durability of Respiratory Syncytial Virus Antibodies After Vaccination in Immunosuppressed Persons. Open Forum Infectious Diseases, 13(8). https://doi.org/10.1093/ofid/ofag453

Vancouver

Nauroz Z, Balasubramanian P, Rodrigues M, Arondekar S, Sengsouk I, Hage C, et al. Durability of Respiratory Syncytial Virus Antibodies After Vaccination in Immunosuppressed Persons. Open Forum Infectious Diseases. 2026;13(8). doi:10.1093/ofid/ofag453

BibTeX
@article{Nauroz2026,
  author = {Nauroz, Zeba and Balasubramanian, Prasanthy and Rodrigues, Moreno and Arondekar, Shreya and Sengsouk, Isabella and Hage, Camille and Chahoud, Maggie and Green, Xori and Gallo, Woudase and Eby, Yolanda and Tobian, Aaron A R and Werbel, William A and Karaba, Andrew H},
  title = {Durability of Respiratory Syncytial Virus Antibodies After Vaccination in Immunosuppressed Persons},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {8},
  doi = {10.1093/ofid/ofag453}
}
Kostenlos starten →